Cargando…

Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology

OBJECTIVE: To analyze clinical features and myopathology changes in muscle fibers, connective tissue, and vessels in 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) antibody–associated myopathies. METHODS: Retrospective review of records and myopathologic features of 49 consecutive patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshehri, Ali, Choksi, Rati, Bucelli, Robert, Pestronk, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459046/ https://www.ncbi.nlm.nih.gov/pubmed/26090508 http://dx.doi.org/10.1212/NXI.0000000000000124

Ejemplares similares

Immune myopathies with perimysial pathology: Clinical and laboratory features
por: Bucelli, Robert C., et al.
Publicado: (2018)

Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018)

Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
por: Ramanathan, Sudarshini, et al.
Publicado: (2015)

Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
por: Kadoya, Masato, et al.
Publicado: (2016)

A case of anti-HMGCR myopathy in a patient with breast cancer and anti-Th/To antibodies
por: Chérif, Mohammad Yassine, et al.
Publicado: (2023)

Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
por: Oh, Eun Kyoung, et al.
Publicado: (2023)

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
por: Mohassel, Payam, et al.
Publicado: (2018)

Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations
por: Kurashige, Takashi, et al.
Publicado: (2020)

Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
por: Munekane, Asami, et al.
Publicado: (2022)

Anti-HMGCR Myopathy without Exposure to Statins: A Case Report
por: Ferriz Vivancos, Jorge, et al.
Publicado: (2022)

From Studio to Rehab: A Debilitating Form of Anti-HMGCR Myopathy
por: Anim-Koranteng, Comfort, et al.
Publicado: (2023)

Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016)

Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies
por: Ikenaga, Chiseko, et al.
Publicado: (2021)

A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy
por: Khan, Nariman, et al.
Publicado: (2022)

Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014)

Anti-HMGCR myopathy misdiagnosed as motor neuron disease and complicated with COVID-19 infection
por: Barp, Andrea, et al.
Publicado: (2021)

Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy
por: SCARD, Camille, et al.
Publicado: (2021)

Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report
por: Thomas, Rhys, et al.
Publicado: (2020)

Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy
por: Ghazal, Fatima, et al.
Publicado: (2023)

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients
por: Meyer, Alain, et al.
Publicado: (2020)

Oral ingestion of collagen peptide causes change in width of the perimysium of the chicken iliotibialis lateralis muscle
por: WATANABE, Takafumi, et al.
Publicado: (2015)

Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy
por: Adler, Brittany, et al.
Publicado: (2022)

Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report
por: Lim, Darosa, et al.
Publicado: (2020)

Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model
por: Julien, Sarah, et al.
Publicado: (2022)

Statin use in patients with non‐HMGCR idiopathic inflammatory myopathies: A retrospective study
por: Bae, Sangmee Sharon, et al.
Publicado: (2020)

Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone
por: Yogev, Yuval, et al.
Publicado: (2023)

Leiomodin-3-deficient mice display nemaline myopathy with fast-myofiber atrophy
por: Tian, Lei, et al.
Publicado: (2015)

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy
por: Aouizerate, Jessie, et al.
Publicado: (2014)

Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure – narrative review of the literature – case report
por: Carvalho, Alzira Alves de Siqueira, et al.
Publicado: (2018)

Anti-HMGCR Specificity of HALIP: A Confirmatory Study
por: Baucells, Andrés, et al.
Publicado: (2020)

Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed
por: Carvalho, Alzira Alves Siqueira, et al.
Publicado: (2018)

Expression of Myomaker and Myomerger in myofibers causes muscle pathology
por: Witcher, Phillip C., et al.
Publicado: (2023)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma, Shizhan, et al.
Publicado: (2019)

The accumulation of muscle RING finger-1 in regenerating myofibers: Implications for muscle repair in immune-mediated necrotizing myopathy
por: Yang, Meng-Ge, et al.
Publicado: (2022)

Case Report: Immune Mediated Necrotizing Myopathy With IgG Antibodies to 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase (HMGCR) May Present With Acute Systolic Heart Failure
por: Ghannam, Malik, et al.
Publicado: (2020)

Dysregulation of lipid metabolism and appearance of slow myofiber-specific isoforms accompany the development of Wooden Breast myopathy in modern broiler chickens
por: Papah, Michael B., et al.
Publicado: (2019)

Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease
por: Szczesny, Piotr, et al.
Publicado: (2022)

Activation of cGAS‐STING pathway – A possible cause of myofiber atrophy/necrosis in dermatomyositis and immune‐mediated necrotizing myopathy
por: Zhou, Meichen, et al.
Publicado: (2022)

Anti-mitochondrial M2 Antibodies and Myopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice
por: Faber, Rachel M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ospf19ms29jf8hsmnb5efsui1v